| Literature DB >> 34716005 |
Arif Nazir1, Annette Wenzler2, JoAnne Reifsnyder3, Richard Feifer3.
Abstract
Entities:
Mesh:
Year: 2021 PMID: 34716005 PMCID: PMC8519660 DOI: 10.1016/j.jamda.2021.09.004
Source DB: PubMed Journal: J Am Med Dir Assoc ISSN: 1525-8610 Impact factor: 4.669
Examples of Collaboration Tactics in Various Domains of the Collaboration Framework: Based on the Experiences of 2 Large Post-Acute and Long-Term Care Organizations∗
| Focus Areas | Domains for Effective Collaboration | ||
|---|---|---|---|
| Bridging Gaps | Negotiating Overlaps | Creating Spaces | |
| Medical, clinical, and operational partnerships | Regular interactions, leveraging videoconferencing | Multiple conversations and debates regarding operationalizing recommendations from the Centers for Disease Control and Prevention (CDC) and state/local public health departments | Daily meetings of varying length that were flexibly scheduled depending on the agenda items, and the availability of busy team members |
| Infection control | Interprofessional committees created at corporate and facility levels | Clear delineation of infection preventionist's responsibilities | COVID-19 units to provide safe and efficient care in SNFs with outbreaks |
| Collaboration with public health officials and the CDC | Establishing communication with various state departments of health and task forces | Providing insights to new protocols around testing and cohorting | Serving on state-level advisory committees, charged with supporting pandemic policy making for nursing homes |
| Medical Director Partnerships | Frequent communications with medical directors on mutual learning of clinical and policy matters | Ensuring medical director is engaged in-person or virtually | Setting frequent calls with medical directors at corporate and facility level |
| Research collaboration between provider, pharmaceutical and academic settings | Facilitating contacts between pharma and academic researchers and SNF leaders by meaningful messaging on value of COVID-19–related research | Helping with practical research designs on several aspects of COVID-19 management, eg, efficacy of monoclonal antibodies and antiviral medications, understanding serologic responses to COVID-19 infections | Regularly scheduled dialog to establish research priorities for SNFs |
These tactics are suggested, experience-based courses of action only and are not intended to be viewed, interpreted, or relied on as required standards or standards of care for the health care industry.